There are currently two approved drugs to treat ALS: riluzole, which can extend lifespan by an average of a few months and has been on the market for 25 年, and the 2017-approved edaravone, which was shown in clinical trials to help patients function for longer into their disease

分类: 干细胞疗法

国家统计局科学

合同研究组织

干细胞疗法